Clinical Prevention and Management of Fetal Growth Restriction

胎儿生长受限(Fetal Growth Restriction, FGR)是导致围产儿死亡的第二大主要原因，对胎儿的近期健康及长期预后均产生显著不良影响。随着现代产前诊断技术的快速发展和对FGR发病机制认识的不断深入，其临床诊断和治疗方案已取得显著进展。然而，目前尚缺乏能够有效改善胎盘功能或促进胎儿体重增长的治疗手段。本文系统综述了FGR的定义标准、临床管理策略及预防措施，以期为临床决策提供循证依据，并探讨该领域未来的研究方向。Fetal Growth Restriction (FGR) is the second leading cause of perinatal mortality and has significant adverse effects on both the immediate health and long-term prognosis of the fetus. With the rapid development of modern prenatal diagnostic techniques and a deeper understanding of the pathogenesis of FGR, notable progress has been made in its clinical diagnosis and treatment strategies. However, there is still a lack of effective therapeutic interventions to improve placental function or promote fetal weight gain. This article systematically reviews the diagnostic criteria, clinical management strategies, and preventive measures for FGR, aiming to provide evidence-based support for clinical decision-making and explore future research directions in this field.